AMED
Amedisys, Inc. · NASDAQ
- Sector Health Services
- Industry Medical/Nursing Services
- Website amedisys.com
- Employees(FY) 18600
- ISIN US0234361089
Performance
-6.26%
1W
-11.56%
1M
-12.31%
3M
-6.78%
6M
-10.03%
YTD
-8.87%
1Y
Profile
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Technical Analysis of AMED 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-06 11:31
- 2024-12-04 17:56
- 2024-12-03 19:00
AMED: Lowering target price to $91.00(Argus Research)
- 2024-11-26 19:00
AMED: Raising target price to $96.00(Argus Research)
- 2024-11-14 15:27
- 2024-11-13 10:25
- 2024-11-12 19:00
AMED: Lowering target price to $96.00(Argus Research)
- 2024-11-12 15:37
Sector Update: Health Care(MT Newswires)
- 2024-11-12 14:42
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys(Associated Press Finance)
- 2024-11-12 14:34
- 2024-11-12 14:32
- 2024-11-12 13:48
- 2024-11-12 12:42
Justice Department Sues to Block UnitedHealth’s $3.3 Billion Bid for Amedisys(The Wall Street Journal)
- 2024-11-12 12:28
Top Midday Decliners(MT Newswires)
- 2024-11-12 12:02
- 2024-11-12 11:40
- 2024-11-12 09:29
- 2024-11-12 09:14
- 2024-11-11 08:40
- 2024-11-06 21:30
- 2024-11-06 19:10
- 2024-11-06 18:09
Amedisys: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-06 16:30
Amedisys Reports Third Quarter 2024 Financial Results(GlobeNewswire)
- 2024-11-06 03:30
Amedisys Reports Third Quarter 2024 Financial Results(Globenewswire)
- 2024-11-05 19:00
AMED: Raising target price to $101.00(Argus Research)
- 2024-11-04 11:40
- 2024-10-31 10:01
- 2024-10-24 04:26
- 2024-10-23 11:02
- 2024-10-16 12:10
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.